{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Directory changed to C:\\Users\\pablosal\\Desktop\\gbb-ai-hls-factory-prior-auth\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "\n",
    "# Define the target directory\n",
    "target_directory = r\"C:\\Users\\pablosal\\Desktop\\gbb-ai-hls-factory-prior-auth\"  # change your directory here\n",
    "\n",
    "# Check if the directory exists\n",
    "if os.path.exists(target_directory):\n",
    "    # Change the current working directory\n",
    "    os.chdir(target_directory)\n",
    "    print(f\"Directory changed to {os.getcwd()}\")\n",
    "else:\n",
    "    print(f\"Directory {target_directory} does not exist.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Instantiate the PolicyIndexingPipeline Class\n",
    "\n",
    "Settings for running the pipeline are in `src\\pipeline\\policyIndexer\\settings.yaml`.\n",
    "\n",
    "The PolicyIndexingPipeline automates the process of indexing policy documents into Azure AI Search."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from src.pipeline.policyIndexer.run import PolicyIndexingPipeline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "indexer = PolicyIndexingPipeline()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Upload Document to Landing Zone Blob Storage"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "## TODO: ALLOW KEY BASED AUTHENTICATION"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:18:21,255 - micro - MainProcess - INFO     Uploaded utils\\data\\cases\\policies\\001.pdf to policies_ocr\\001.pdf (run.py:upload_documents:140)\n",
      "2024-11-10 14:18:21,341 - micro - MainProcess - INFO     Uploaded utils\\data\\cases\\policies\\002.pdf to policies_ocr\\002.pdf (run.py:upload_documents:140)\n",
      "2024-11-10 14:18:21,407 - micro - MainProcess - INFO     Uploaded utils\\data\\cases\\policies\\003.pdf to policies_ocr\\003.pdf (run.py:upload_documents:140)\n",
      "2024-11-10 14:18:21,501 - micro - MainProcess - INFO     Uploaded utils\\data\\cases\\policies\\004.pdf to policies_ocr\\004.pdf (run.py:upload_documents:140)\n",
      "2024-11-10 14:18:21,579 - micro - MainProcess - INFO     Uploaded utils\\data\\cases\\policies\\005.pdf to policies_ocr\\005.pdf (run.py:upload_documents:140)\n"
     ]
    }
   ],
   "source": [
    "indexer.upload_documents(local_path=\"utils\\data\\cases\\policies\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Create Data Source (Connect Blob)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:18:28,538 - micro - MainProcess - INFO     Data source 'ai-policies-blob' created or updated (run.py:create_data_source:163)\n"
     ]
    }
   ],
   "source": [
    "indexer.create_data_source()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Create Index "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:18:32,476 - micro - MainProcess - INFO     Index 'ai-policies-index' created or updated successfully. (run.py:create_index:277)\n"
     ]
    }
   ],
   "source": [
    "indexer.create_index()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Creare Skillset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:18:39,935 - micro - MainProcess - INFO     Skillset 'ai-policies-skillset' created or updated (run.py:create_skillset:429)\n"
     ]
    }
   ],
   "source": [
    "indexer.create_skillset()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Create Indexer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:18:53,615 - micro - MainProcess - INFO     Indexer 'ai-policies-indexer' created or updated (run.py:create_indexer:464)\n"
     ]
    }
   ],
   "source": [
    "indexer.create_indexer()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Create Run Indexer "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "from src.pipeline.policyIndexer.run import IndexerRunner"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "indexer = IndexerRunner(indexer_name=\"ai-policies-indexer\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:19:17,112 - micro - MainProcess - INFO     Indexer 'ai-policies-indexer' has been started. (run.py:run_indexer:533)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-11-10 14:19:17,168 - micro - MainProcess - INFO     Indexer Status: running (run.py:monitor_indexer_status:575)\n",
      "2024-11-10 14:19:17,169 - micro - MainProcess - INFO     Last Run Time: 2024-11-10 20:19:12.790000+00:00 (run.py:monitor_indexer_status:576)\n",
      "2024-11-10 14:19:17,171 - micro - MainProcess - INFO     Execution Status: success (run.py:monitor_indexer_status:577)\n",
      "2024-11-10 14:19:17,173 - micro - MainProcess - INFO     Indexer 'ai-policies-indexer' completed successfully. (run.py:monitor_indexer_status:583)\n"
     ]
    }
   ],
   "source": [
    "indexer.monitor_indexer_status()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Test Search "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from azure.search.documents import SearchClient\n",
    "from azure.search.documents.models import VectorizableTextQuery\n",
    "from azure.core.credentials import AzureKeyCredential\n",
    "\n",
    "credential = (\n",
    "    AzureKeyCredential(os.getenv(\"AZURE_AI_SEARCH_ADMIN_KEY\"))\n",
    "    if os.getenv(\"AZURE_AI_SEARCH_ADMIN_KEY\")\n",
    "    else DefaultAzureCredential()\n",
    ")\n",
    "index_name = os.getenv(\"AZURE_AI_SEARCH_INDEX_NAME\", \"ai-policies-index\")\n",
    "\n",
    "\n",
    "search_client = SearchClient(\n",
    "    endpoint=os.environ[\"AZURE_AI_SEARCH_SERVICE_ENDPOINT\"],\n",
    "    index_name=index_name,\n",
    "    credential=AzureKeyCredential(os.environ[\"AZURE_AI_SEARCH_ADMIN_KEY\"]),\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "SEARCH_QUERY = \"afiniitor therapy\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "vector_query = VectorizableTextQuery(\n",
    "    text=SEARCH_QUERY, k_nearest_neighbors=5, fields=\"vector\", weight=0.5\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "def format_azure_search_results(results: list, truncate: int = 1000) -> str:\n",
    "    \"\"\"\n",
    "    Formats Azure AI Search results into a structured, readable string.\n",
    "    \n",
    "    Each result contains:\n",
    "    - Chunk ID\n",
    "    - Reranker Score\n",
    "    - Source Document Path\n",
    "    - Content (truncated to the specified number of characters if too long)\n",
    "    - Caption (highlighted if available)\n",
    "    \n",
    "    :param results: List of results from the Azure AI Search API.\n",
    "    :param truncate: Maximum number of characters to include in the content before truncating.\n",
    "    :return: Formatted string representation of the search results.\n",
    "    \"\"\"\n",
    "    formatted_results = []\n",
    "\n",
    "    for result in results:\n",
    "        # Access all properties like a dictionary\n",
    "        chunk_id = result['chunk_id'] if 'chunk_id' in result else 'N/A'\n",
    "        reranker_score = result['@search.reranker_score'] if '@search.reranker_score' in result else 'N/A'\n",
    "        source_doc_path = result['parent_path'] if 'parent_path' in result else 'N/A'\n",
    "        content = result['chunk'] if 'chunk' in result else 'N/A'\n",
    "        \n",
    "        # Truncate content to specified number of characters\n",
    "        content = content[:truncate] + \"...\" if len(content) > truncate else content\n",
    "\n",
    "        # Extract caption (highlighted caption if available)\n",
    "        captions = result['@search.captions'] if '@search.captions' in result else []\n",
    "        caption = \"Caption not available\"\n",
    "        if captions:\n",
    "            first_caption = captions[0]\n",
    "            if first_caption.highlights:\n",
    "                caption = first_caption.highlights\n",
    "            elif first_caption.text:\n",
    "                caption = first_caption.text\n",
    "\n",
    "        # Format each result section\n",
    "        result_string = (\n",
    "            f\"========================================\\n\"\n",
    "            f\"ðŸ†” ID: {chunk_id}\\n\"\n",
    "            f\"ðŸ“ˆ Reranker Score: {reranker_score}\\n\"\n",
    "            f\"ðŸ“‚ Source Doc Path: {source_doc_path}\\n\"\n",
    "            f\"ðŸ“œ Content: {content}\\n\"\n",
    "            f\"ðŸ’¡ Caption: {caption}\\n\"\n",
    "            f\"========================================\"\n",
    "        )\n",
    "\n",
    "        formatted_results.append(result_string)\n",
    "\n",
    "    # Join all the formatted results into a single string\n",
    "    return \"\\n\\n\".join(formatted_results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "from azure.search.documents.models import QueryType, QueryCaptionType, QueryAnswerType\n",
    "\n",
    "results = search_client.search(\n",
    "    search_text=SEARCH_QUERY,\n",
    "    vector_queries=[vector_query],\n",
    "    query_type=QueryType.SEMANTIC,\n",
    "    semantic_configuration_name=\"my-semantic-config\",\n",
    "    query_caption=QueryCaptionType.EXTRACTIVE,\n",
    "    query_answer=QueryAnswerType.EXTRACTIVE,\n",
    "    top=5,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "========================================\n",
      "ðŸ†” ID: 677854350e06_aHR0cHM6Ly9zdG9yYWdlYWVhc3R1c2ZhY3RvcnkuYmxvYi5jb3JlLndpbmRvd3MubmV0L3ByZS1hdXRoLXBvbGljaWVzL3BvbGljaWVzX29jci8wMDUucGRm0_normalized_images_10_pages_0\n",
      "ðŸ“ˆ Reranker Score: 2.7419040203094482\n",
      "ðŸ“‚ Source Doc Path: https://storageaeastusfactory.blob.core.windows.net/pre-auth-policies/policies_ocr/005.pdf\n",
      "ðŸ“œ Content: UnitedHealthcareÂ® (2) Presence of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutation Authorization will be issued for 12 months. 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. Q. Gastrointestingal Stromal Tumor (GIST) 1. Initial Authorization a. Afinitor will be approved based on all of the following criteria: (1) Diagnosis of Gastrointestinal Stromal Tumor (GIST) -AND- (2) Disease is one of the following: (a) Unresectable (b) Progressive (c) Metastatic (d) Gross residual (R2 resection) (e) Tumor rupture -AND- (3) Disease has progressed after single agent therapy with all of the following: (a) Imatinib (Gleevec) (b) Sutent (sunitinib) (c) Stivarga (regorafenib) (d) Qinlock (ripretinib) -AND- (4) Used in combination with one of the following: (a) Imatinib (Gleevec) (b) Sutent (sunitinib) (...\n",
      "ðŸ’¡ Caption: <em>Afinitor will be approved </em>based on the following criterion: (1)<em> Patient does not show evidence of progressive disease </em>while on<em> Afinitor therapy Authorization </em>will be issued for<em> 12 months.</em>  ...fter single agent therapy with all of the following: (a) Imatinib (Gleevec) (b) Sutent (sunitinib) (c) Stivarga (regorafenib) (d) Qinlock (ripretinib) -AND-.\n",
      "========================================\n",
      "\n",
      "========================================\n",
      "ðŸ†” ID: 677854350e06_aHR0cHM6Ly9zdG9yYWdlYWVhc3R1c2ZhY3RvcnkuYmxvYi5jb3JlLndpbmRvd3MubmV0L3ByZS1hdXRoLXBvbGljaWVzL3BvbGljaWVzX29jci8wMDUucGRm0_normalized_images_5_pages_0\n",
      "ðŸ“ˆ Reranker Score: 2.6646296977996826\n",
      "ðŸ“‚ Source Doc Path: https://storageaeastusfactory.blob.core.windows.net/pre-auth-policies/policies_ocr/005.pdf\n",
      "ðŸ“œ Content: UnitedHealthcareÂ® (a) Exemestane if progressed within 12 months or on a non-steroidal aromatase inhibitor [e.g ., Arimidex (anastrozole), Femara (letrozole)] (b) Fulvestrant (c) Tamoxifen Authorization will be issued for 12 months. 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. H. Hodgkin Lymphoma 1. Initial Authorization a. Afinitor will be approved based on both of the following criteria: (1) Diagnosis of classic Hodgkin lymphoma -AND- (2) Disease is refractory to at least 3 prior lines of therapy Authorization will be issued for 12 months. 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. I. Soft Tissue Sarcoma 1. Initial Authorization a. Afinitor will be approved b...\n",
      "ðŸ’¡ Caption: <em>Afinitor </em>will be<em> approved </em>based on the following criterion: (1) Patient<em> does not show evidence of progressive disease </em>while on<em> Afinitor therapy Authorization </em>will be issued for<em> 12 months.</em> <em>Afinitor </em>will<em> be approved </em>based on both of the following criteria: (1)<em> Diagnosis of </em>classic<em> Hodgkin lymphoma </em>-AND- (2) Disease is refractory to at least 3 prior.\n",
      "========================================\n",
      "\n",
      "========================================\n",
      "ðŸ†” ID: 677854350e06_aHR0cHM6Ly9zdG9yYWdlYWVhc3R1c2ZhY3RvcnkuYmxvYi5jb3JlLndpbmRvd3MubmV0L3ByZS1hdXRoLXBvbGljaWVzL3BvbGljaWVzX29jci8wMDUucGRm0_normalized_images_8_pages_0\n",
      "ðŸ“ˆ Reranker Score: 2.6422979831695557\n",
      "ðŸ“‚ Source Doc Path: https://storageaeastusfactory.blob.core.windows.net/pre-auth-policies/policies_ocr/005.pdf\n",
      "ðŸ“œ Content: UnitedHealthcareÂ® Authorization will be issued for 12 months. 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. M. Endometrial Carcinoma 1. Initial Authorization a. Afinitor will be approved based on all of the following criteria: (1) Diagnosis of endometrial carcinoma -AND- (2) Used in combination with letrozole Authorization will be issued for 12 months. 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. N. Tuberous Sclerosis Complex associated Partial-onset Seizures 1. Initial Authorization a. Afinitor will be approved based on both of the following criteria: (1) Diagnosis of tuberous sclerosis complex associated partial-onset seizures -AND- (2) Used as adjunctive thera...\n",
      "ðŸ’¡ Caption: Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months.  ... of progressive disease while on Afinitor therapy Authorization will be issued for 12 monthsAfinitor will be approved based on both of the following.\n",
      "========================================\n",
      "\n",
      "========================================\n",
      "ðŸ†” ID: 677854350e06_aHR0cHM6Ly9zdG9yYWdlYWVhc3R1c2ZhY3RvcnkuYmxvYi5jb3JlLndpbmRvd3MubmV0L3ByZS1hdXRoLXBvbGljaWVzL3BvbGljaWVzX29jci8wMDUucGRm0_normalized_images_6_pages_0\n",
      "ðŸ“ˆ Reranker Score: 2.621384382247925\n",
      "ðŸ“‚ Source Doc Path: https://storageaeastusfactory.blob.core.windows.net/pre-auth-policies/policies_ocr/005.pdf\n",
      "ðŸ“œ Content: UnitedHealthcareÂ® 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. J. Thymomas and Thymic Carcinomas 1. Initial Authorization a. Afinitor will be approved based on both of the following criteria: (1) One of the following: (a) Diagnosis of thymic carcinoma (b) Diagnosis of thymoma -AND- (2) One of the following: (a) First-line therapy as a single agent for those who cannot tolerate first-line combination regimens (b) Second-line therapy as a single agent Authorization will be issued for 12 months. 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. K. Thyroid Carcinoma 1. Initial Authorization a. Afinitor will be approved based on all of the following criteria: (1) Diagnosi...\n",
      "ðŸ’¡ Caption: ...g criterion: (1) P does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 monthsAfinitor will be approved based on both of the following criteria: (1) One of the following: (a) Diagnosis of thymic carcinoma (b) Diagnosis of thymoma -AND- (2) One of the following: (a) First-line therapy as a.\n",
      "========================================\n",
      "\n",
      "========================================\n",
      "ðŸ†” ID: 677854350e06_aHR0cHM6Ly9zdG9yYWdlYWVhc3R1c2ZhY3RvcnkuYmxvYi5jb3JlLndpbmRvd3MubmV0L3ByZS1hdXRoLXBvbGljaWVzL3BvbGljaWVzX29jci8wMDUucGRm0_normalized_images_11_pages_0\n",
      "ðŸ“ˆ Reranker Score: 2.609686851501465\n",
      "ðŸ“‚ Source Doc Path: https://storageaeastusfactory.blob.core.windows.net/pre-auth-policies/policies_ocr/005.pdf\n",
      "ðŸ“œ Content: UnitedHealthcareÂ® 2. Reauthorization a. Afinitor will be approved based on the following criterion: (1) Patient does not show evidence of progressive disease while on Afinitor therapy Authorization will be issued for 12 months. R. NCCN Recommended Regimens The drug has been recognized for treatment of the cancer indication by The National Comprehensive Cancer Network (NCCN) Drugs and Biologics Compendium with a Category of Evidence and Consensus of 1, 2A, or 2B Authorization will be issued for 12 months. a State mandates may apply. Any federal regulatory requirements and the member specific benefit plan coverage may also impact coverage criteria. Other policies and utilization management programs may apply. 3. Additional Clinical Rules: Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-authorization based solely on previous claim/medication history, diagnosis codes (ICD-10) and/or claim logic. Use of automated approval and re-approval processes varies by pr...\n",
      "ðŸ’¡ Caption: UnitedHealthcareÂ® 2. Reauthorization a. <em>Afinitor will be approved </em>based on the following criterion: (1) Patient does not show evidence of<em> progressive disease </em>while on<em> Afinitor therapy Authorization </em>will be<em> issued for 12 months.</em> NCCN Recommended Regimens The drug has been recognized for treatment of the cancer indication by The National.\n",
      "========================================\n"
     ]
    }
   ],
   "source": [
    "result = format_azure_search_results(results)\n",
    "print(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "str"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(result)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "pa-ai-env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.15"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
